Rambaldi, Alessandro <br/><br/>
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.  [electronic resource] 

 -  Leukemia  08 2020 
 - 2234-2237 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/s41375-020-0735-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carbamates--adverse effects<br/>Female<br/>Humans<br/>Janus Kinase 2--genetics<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Mutation<br/>Polycythemia Vera--drug therapy<br/>Quality of Life